WHO ICTRP trial
â??Utility of olanzapine for prevention of nausea and vomiting in children and…
CTRI/2017/07/009092 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/07/009092 |
|---|---|
| Public title | â??Utility of olanzapine for prevention of nausea and vomiting in children and young adults receiving cancer chemotherapy. |
| Scientific title | â??Olanzapine for prevention of nausea and vomiting in Children and Adolescents receiving Highly emetogenic chemotherapy (HEC): An Investigator Initiated, Randomized, Open-label Trialâ?? |
| Primary sponsor | AIIMS |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Children and adolescents (5-18 years) with weight between 15-65 kg receiving HEC at Dr. BRA IRCH, AIIMS and are able to swallow the study medication. Health Condition 2: C419- Malignant neoplasm of bone and… |
| Interventions | Intervention1: Olanzapine: Experimental arm will receive standard anti emetic prophylaxis plus olanzapine i.e, ondansetron plus dexamethasone plus aprepitant plus olanzapine as scheduled below: Experimental group (ODAO): weight category of… |
| Registration date | Jul 21, 2017 |
| Target size | 240 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: